BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 29718274)

  • 1. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
    Namura K; Minamimoto R; Yao M; Makiyama K; Murakami T; Sano F; Hayashi N; Tateishi U; Ishigaki H; Kishida T; Miura T; Kobayashi K; Noguchi S; Inoue T; Kubota Y; Nakaigawa N
    BMC Cancer; 2010 Dec; 10():667. PubMed ID: 21129184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan.
    Chen SH; Chan SC; Chao YK; Yen TC
    PLoS One; 2013; 8(11):e82812. PubMed ID: 24312435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting recurrent disease and surgical outcomes in patients with locally advanced tongue cancer after multimodal treatment using ¹⁸F-FDG-PET/CT.
    Chen WL; Zhou B; Huang ZX; Dong XY; Chen R
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3):101673. PubMed ID: 37923135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of sacral chordoma and differential diagnosis from other sacral malignancy using [18F]FDG PET/CT.
    Lee DY; Kim YI; Ryu JS; Kim W
    Medicine (Baltimore); 2024 Apr; 103(14):e37678. PubMed ID: 38579025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study.
    Lee JW; Ahn H; Yoo ID; Hong SP; Baek MJ; Kang DH; Lee SM
    Cancer Imaging; 2024 Apr; 24(1):53. PubMed ID: 38627864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodies.
    Frelau A; Palard-Novello X; Jali E; Boussemart L; Dupuy A; James P; Devillers A; Le Jeune F; Edeline J; Lesimple T; Girard A
    Cancer Immunol Immunother; 2021 Mar; 70(3):679-687. PubMed ID: 32880684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the maximum standardized uptake value for the diagnosis and staging of patients with cervical cancer undergoing positron emission tomography/computed tomography.
    Takagi H; Sakamoto J; Osaka Y; Shibata T; Fujita S; Sasagawa T
    Medicine (Baltimore); 2018 Feb; 97(7):e9856. PubMed ID: 29443749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated splenic 18F-fluorodeoxyglucose positron emission tomography/computed tomography activity is associated with 5-year risk of recurrence in non-metastatic invasive ductal carcinoma of the breast.
    Wang Y; Li Y; Jiang H; Zuo C; Xu W
    Br J Radiol; 2024 Jan; 97(1153):237-248. PubMed ID: 38263821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy.
    Cavanagh K; McLean LS; Lim AM; Cardin A; Levy SM; Rischin D
    Cancer Imaging; 2024 Mar; 24(1):37. PubMed ID: 38500235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Diffuse Hot Pleura" in a Case of Recurrent Squamous Cell Carcinoma of the Foot: 18 F-FDG PET/CT Findings.
    Ashwathanaryana AG; Krishna S; Chaturmohta A; Joshi P; Asrani S
    Clin Nucl Med; 2024 May; 49(5):e233-e234. PubMed ID: 38498681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of qualitative assessment in detecting synchronous and metachronous malignancies in adult cancer patients by 18F-FDG PET/CT.
    Lau JHY; Ng KK; Wong WC; Ng KS; Chu KS; Au-Yong TK; Kung BT
    Nucl Med Commun; 2024 May; ():. PubMed ID: 38726624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximum standardized uptake value in
    Kuroshima T; Kitagawa Y; Sato J; Watanabe S; Asaka T; Abe T; Harada H; Hirata K; Kuge Y
    Odontology; 2024 May; ():. PubMed ID: 38703257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A black adrenal adenoma with high FDG uptake on PET/CT scan in a patient with esophageal carcinoma: A case report.
    Matsumoto S; Hosoya Y; Lefor AK; Haruta H; Ui T; Kurashina K; Saito S; Ashizawa K; Sasaki T; Kitayama J; Sata N
    Int J Surg Case Rep; 2018; 44():118-121. PubMed ID: 29499515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast.
    Ueda S; Nakamiya N; Matsuura K; Shigekawa T; Sano H; Hirokawa E; Shimada H; Suzuki H; Oda M; Yamashita Y; Kishino O; Kuji I; Osaki A; Saeki T
    BMC Cancer; 2013 Oct; 13():514. PubMed ID: 24176197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significantly Elevated FDG Activity in Neurothekeoma.
    Amiruddin R; Zhuang H
    Clin Nucl Med; 2024 Jun; 49(6):597-599. PubMed ID: 38537202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron Emission Tomography (PET) in Oncology.
    Gallamini A; Zwarthoed C; Borra A
    Cancers (Basel); 2014 Sep; 6(4):1821-89. PubMed ID: 25268160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT in leukemia: utility and future directions.
    Al-Ibraheem A; Allouzi S; Abdlkadir AS; Mikhail-Lette M; Al-Rabi K; Ma'koseh M; Knoll P; Abdelrhman Z; Shahin O; Juweid ME; Paez D; Lopci E
    Nucl Med Commun; 2024 Apr; ():. PubMed ID: 38646840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Maximum standardized uptake value in 
    Kuroshima T; Kitagawa Y; Sato J; Watanabe S; Asaka T; Abe T; Harada H; Hirata K; Kuge Y
    Odontology; 2024 May; ():. PubMed ID: 38767723
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).
    Yamaga E; Toriihara A; Nakamura S; Asai S; Fujioka T; Yoshimura R; Michi Y; Harada H; Tateishi U
    Jpn J Clin Oncol; 2018 Jul; 48(7):633-639. PubMed ID: 29718274
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.